Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia.
about
Strategies to minimize antibiotic resistanceHealthcare-Associated Pneumonia Does Not Accurately Identify Potentially Resistant Pathogens: A Systematic Review and Meta-AnalysisGuideline-based antibiotics and mortality in healthcare-associated pneumoniaEvaluation of early mini-bronchoalveolar lavage in the diagnosis of health care-associated pneumonia: a prospective studyHealthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital.Defining and predicting severe community-acquired pneumonia.Antibiotic Prescribing for Adults Hospitalized in the Etiology of Pneumonia in the Community StudyEpidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.Surviving the first hours in sepsis: getting the basics right (an intensivist's perspective).Additional risk factors for infection by multidrug-resistant pathogens in healthcare-associated infection: a large cohort studyValidation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study.Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia.One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System.Classification of healthcare-associated infection: a systematic review 10 years after the first proposalDefining severe pneumonia.Application and comparison of scoring indices to predict outcomes in patients with healthcare-associated pneumoniaComparison of clinical prediction models for resistant bacteria in community-onset pneumonia.Application of a methicillin-resistant Staphylococcus aureus risk score for community-onset pneumonia patients and outcomes with initial treatmentOutcomes of patients with healthcare-associated pneumonia: worse disease or sicker patients?Risk factors to predict drug-resistant pathogens in hemodialysis-associated pneumonia.Healthcare-associated Pneumonia: Clinical Features and Retrospective Analysis Over 10 Years.Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumoniaDerivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score.Update in community-acquired and nosocomial pneumonia 2009.Management of community-acquired pneumonia: a review and update.Emergency pharmacist impact on health care-associated pneumonia empiric therapy.Guideline-concordant antimicrobial therapy for healthcare-associated pneumonia: a systematic review and meta-analysis.Healthcare-associated pneumonia: a US disease or relevant to the Asia Pacific, too?The bacterial pneumonias: a new treatment paradigm.The role of azithromycin in healthcare-associated pneumonia treatment.Personalized treatment of severe pneumonia in cancer patients.Regional differences in antibiotic-resistant pathogens in patients with pneumonia: Implications for clinicians.Application of a Risk Score to Identify Older Adults with Community-Onset Pneumonia Most Likely to Benefit From Empiric Pseudomonas Therapy.Impact of Combination Antibiogram and Related Education on Inpatient Fluoroquinolone Prescribing Patterns for Patients With Health Care-Associated Pneumonia.Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia.Should the patients colonized with extended-spectrum beta-lactamase-producing gram-negative bacilli (E-GNB) coming to hospital from the community with pneumonia get anti-E-GNB active empirical treatment?Nursing home-acquired pneumonia presenting at the emergency department.Clinical and microbiological features of patients admitted to the intensive care unit with nursing and healthcare-associated pneumonia.Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.Impact of aspiration pneumonia in patients with community-acquired pneumonia and healthcare-associated pneumonia: a multicenter retrospective cohort study.
P2860
Q24607946-9CF1E9CA-15C8-404A-B753-4F24FE75EF27Q29543747-E9401ACC-0452-4F97-9108-8226ACF57AD6Q30516569-4A2B7FE7-353D-4967-AE0E-1B94D69F6A0BQ33750013-954F1EC1-140A-41FB-9948-46A9AF7834F4Q33843896-1629CDC8-00F1-4922-B773-06F8388C8CB5Q33872274-48545948-A9B7-44A6-9EBC-DCA146A97C24Q33904263-8BD8B161-EBB2-445E-AF37-76180F25C7C2Q34057602-EFB6BD37-5248-4E4B-B27E-0F953AEC9F00Q34170333-AF8F2C78-2B1A-47CF-AFA2-05B3DD57C24FQ34522760-B3D8B10D-EB38-470B-ACF6-B35CF903B55FQ34874096-33704081-7200-4711-94AC-F06E8E40EF16Q34928386-D99219BB-A7C0-4CA2-9DA7-00D158AADBA5Q34984823-F0A56FEE-EC91-4D62-82C0-B3FE53E0944FQ35111689-FD6D9A5E-3BA4-4254-9EEA-68A81375F729Q35184605-13CE6D1E-F70F-48DC-9C22-1C40507C481CQ35567266-B3CCAE2E-F63B-4680-AFB9-5A15F905030FQ35732814-735B9951-EEC2-4FC9-A9D3-5053A9D18870Q35780916-DBC20377-4EB6-4C04-8A4B-4FA9F789845BQ36024061-1CBB20D1-85AB-4148-9368-79D678FDD32BQ36098026-5B24E398-8BA2-4B28-B1F6-A8FC89EA3AB6Q36531884-75F07287-74BC-4008-9171-87E531FC848DQ36864493-E814EFFB-FA10-4137-AC73-DF467D475B84Q36888089-FAC43300-E964-46AC-B889-83608921DCBAQ37728782-A97EF6CE-96DC-47D1-9CD2-46320C5B1379Q37799174-2E0E89CB-2130-4F8F-A84B-9165D2D02C02Q38037476-28A1B922-72D6-4FCF-A958-62618A66B5CEQ38097737-5AD48D83-CCB6-49C7-969E-4C2D93D3A019Q38109968-2B7B8E9B-7029-47EB-B8BD-4CEC9F6BD02BQ38307688-45ABFA50-B1FD-465C-BD61-1209E89BA3BAQ38570217-FB69D76F-F676-4B81-A0AE-887CE3199661Q38613281-71BBC2BC-85D6-4496-A660-10845FAD6E35Q38646554-45D349B2-B697-48F6-B832-13CE128F52F7Q39051283-83DC90B7-858D-41CE-A637-DC7B47C36F37Q40090523-EDA928F5-C527-4121-A7F6-BEC5E8D2104DQ40196287-976359DE-2B3B-42D9-9CE3-8ABF4BEE7D98Q40428378-B48FBF0A-04AA-4B0A-8FA1-5E687A4A373FQ40764625-BB7C331C-324D-4EBD-B0D3-55DA6EDA11C9Q41560626-381E665F-1A18-4838-99DF-B416C64106F8Q42608997-D1E84713-58F5-4D0E-8C42-4C5BC703C3ADQ44402736-A18D559E-4217-4560-BDBF-A3771801905E
P2860
Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Healthcare-associated pneumoni ...... complex nosocomial pneumonia.
@en
Healthcare-associated pneumoni ...... complex nosocomial pneumonia.
@nl
type
label
Healthcare-associated pneumoni ...... complex nosocomial pneumonia.
@en
Healthcare-associated pneumoni ...... complex nosocomial pneumonia.
@nl
prefLabel
Healthcare-associated pneumoni ...... complex nosocomial pneumonia.
@en
Healthcare-associated pneumoni ...... complex nosocomial pneumonia.
@nl
P921
P1476
Healthcare-associated pneumoni ...... complex nosocomial pneumonia.
@en
P2093
Michael S Niederman
Veronica Brito
P304
P356
10.1097/QCO.0B013E328329FA4E
P577
2009-06-01T00:00:00Z